PharmAla Biotech and Filament Health Announce Release of GMP MDMA Capsules
11 avr. 2023 08h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, April 11, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”) (CSE:MDMA), a Canadian biotechnology company dedicated to the research and development of...
Societal CDMO Reports Inducement Grants for New Staff
06 avr. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., April 06, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Harmony Biosciences Holdings Shareholder News: Johnson Fistel Urges Investors with Losses to Reach Out Regarding Class Action Investigation - HRMY
28 mars 2023 19h30 HE
|
Johnson Fistel, LLP
SAN DIEGO, March 28, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating whether Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), any of its executive...
Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
15 mars 2023 16h11 HE
|
Catalyst Pharmaceuticals, Inc.
Achieved Record 2022 Total Net Revenues of $214 Million, a 52% YoY Increase Achieved FIRDAPSE® Q4 2022 Net Product Revenues of $61 Million, a 59% YoY Increase Newly Acquired FYCOMPA® Product...
Dyspepsia Treatment Market to advancement at a CAGR of 4.1% during 2022–2031, as demand for non-invasive treatment is growing | TMR Study
10 mars 2023 14h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, March 11, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – In 2021, the Global Dyspareunia Treatment Market size was worth US$ 689.0 Mn. Dyspareunia...
Incannex Engages Catalent for Development and cGMP Manufacture of Psilocybin Drug Product for Clinical Trials and Potential Commercial Use
03 mars 2023 07h30 HE
|
Incannex Healthcare
Highlights: Incannex has engaged Catalent for the development and cGMP manufacture of Incannex’s own psilocybin drug product.The psilocybin is designed for use in Incannex’s ongoing...
PharmAla Biotech named Exclusive MDMA Supply Partner to Awakn Life Sciences
02 mars 2023 08h35 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research, development, and...
OKYO Pharma Announces Custom Clearance of GMP Packaged OK-101 Drug to be Used in Phase 2 Clinical Trial for Treating Dry Eye Disease
28 févr. 2023 02h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Feb. 28, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye...
Patent Application Published for PharmAla Biotech’s MDMA Analogs
23 févr. 2023 08h00 HE
|
PharmAla Biotech
VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech (CSE:MDMA) is pleased to announce the publication of a key Patent Cooperation Treaty (PCT) application containing 6...
Tamiflu (Oseltamivir Phosphate) Market to Surpass US$ 978.6 Million by 2030, Says Coherent Market Insights (CMI)
20 févr. 2023 10h00 HE
|
CMI
Burlingame, Feb. 20, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global Tamiflu (oseltamivir phosphate) market is estimated to be valued at US$ 889.2 million in 2022 and is...